Advertisement

Disorders of the Krebs Cycle

  • Eva MoravaEmail author
  • Rosalba Carrozzo
Chapter

Abstract

This chapter focuses on two classic Krebs cycle disorders (2-oxoglutaric aciduria and fumarase deficiency) and two recently discovered disorders of the Krebs cycle, severely affecting mitochondrial function and mitochondrial maintenance (succinyl-CoA synthetase –SCS – deficiencies, characterized by mutations in SUCLA2 and SUCLG1 genes). Fumarase deficiency and 2-oxoglutaric aciduria are rare disorders with global developmental delay and severe neurologic problems in infants. Patients with oxoglutaric aciduria have a variable severity of neurological involvement and metabolic acidosis and develop severe microcephaly and mental retardation. A special form (DOOR syndrome) occurs with sensorineural deafness and osteodystrophy. Patients with fumarase deficiency present with either a fulminant course associated with fatal outcome within the first 2 years of life or a subacute encephalopathy with profound speech delay without metabolic crises. SUCLA2 and SUCLG1 defects have the clinical presentation of mitochondrial depletion syndromes with profound hypotonia, progressive dystonia, and muscular atrophy, in addition to severe sensorineural hearing impairment, which has been specifically associated with SUCLA2 defect. The most important clues for the diagnosis in all these disorders rely in urine organic analysis. 2-oxoglutaric aciduria leads to chronic metabolic acidosis and variable urinary excretion of 2-oxoglutarate, while fumarase deficiency occurs with an increased excretion of fumarate associated with succinate and lactate excretion with eventual 2-oxoglutaric aciduria. A normal excretion of fumaric acid and a relative high fumarase residual activity do not rule out fumarase deficiency. In questionable cases mutation analysis is needed to confirm the diagnosis. In SCS defects mild methylmalonic aciduria with abnormal urine carnitine-ester profile is associated with only subtle abnormalities of the Krebs cycle intermediates. Due to the recognizable pattern of dystonia/±deafness syndrome and mild methylmalonic aciduria in SCS defects, direct genetic testing is a possible approach in the diagnosis of SUCLA2 and SUCLG1 defects. Carrier screening in fumarase deficiency is important due to the possible increased risk for certain malignancies.

Keywords

Fumaric Acid Papillary Renal Cell Carcinoma Methylmalonic Acid Fumarate Hydratase Molecular Genetic Testing 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Allegri G, Fernandes MJ, Scalco FB et al (2010) Fumaric aciduria: an overview and the first Brazilian case report. J Inherit Metab Dis 33:411–419PubMedCrossRefGoogle Scholar
  2. Bonnefont JP, Chretien D, Rustin P et al (1992) Alpha-ketoglutarate dehydrogenase deficiency presenting as congenital lactic acidosis. J Pediatr 121:255–258PubMedCrossRefGoogle Scholar
  3. Carrozzo R, Dionisi-Vici C, Steuerwald U et al (2007) SUCLA2 mutations are associated with mild methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness. Brain 130:862–874PubMedCrossRefGoogle Scholar
  4. Coughlin EM, Christensen E, Kunz PL et al (1998) Molecular analysis and prenatal diagnosis of human fumarase deficiency. Mol Genet Metab 63:254–262PubMedCrossRefGoogle Scholar
  5. De Meirleir L, Hansikova H, Zeman J et al (2006) Fumarate hydratase deficiency – a rare cause of development delay and seizures. J Inherit Metab Dis 29:106–108CrossRefGoogle Scholar
  6. Deodato F, Boenzi S, Santorelli FM, Dionisi-Vici C (2006) Methylmalonic and propionic aciduria. Am J Med Genet C Semin Med Genet 142:104–112CrossRefGoogle Scholar
  7. Elpeleg O, Miller C, Hershkovitz E et al (2005) Deficiency of the ADP-forming succinyl-CoA synthase activity is associated with encephalomyopathy and mitochondrial DNA depletion. Am J Hum Genet 76:1081–1086PubMedCentralPubMedCrossRefGoogle Scholar
  8. Guffon N, Lopez-Mediavilla C, Dumoulin R et al (1993) 2-ketoglutarate dehydrogenase deficiency, a rare cause of primary hyperlactataemia: report of a new case. J Inherit Metab Dis 16:821–830PubMedCrossRefGoogle Scholar
  9. Johnson JD, Muhonen WW, Lambeth DO (1998) Characterization of the ATP- and GTP-specific succinyl-CoA synthetases in pigeon. The enzymes incorporate the same alpha-subunit. J Biol Chem 273:27573–27579PubMedCrossRefGoogle Scholar
  10. Kadrmas EF, Ray PD, Lambeth DO (1991) Apparent ATP-linked succinate thiokinase activity and its relation to nucleoside diphosphate kinase in mitochondrial matrix preparations from rabbit. Biochim Biophys Acta 1074:339–346PubMedCrossRefGoogle Scholar
  11. Kavanaugh-Black A, Connolly DM, Chugani SA, Chakrabarty AM (1994) Characterization of nucleoside-diphosphate kinase from Pseudomonas aeruginosa: complex formation with succinyl-CoA synthetase. Proc Natl Acad Sci U S A 91:5883–5887PubMedCentralPubMedCrossRefGoogle Scholar
  12. Kohlschutter A, Behbehani A, Langenbeck U et al (1982) A familial progressive neurodegenerative disease with 2-oxoglutaric aciduria. Europ J Pediatr 138:32–37CrossRefGoogle Scholar
  13. Kowluru A, Tannous M, Chen HQ (2002) Localization and characterization of the mitochondrial isoform of the nucleoside diphosphate kinase in the pancreatic beta cell: evidence for its complexation with mitochondrial succinyl-CoA synthetase. Arch Biochem Biophys 398:160–169PubMedCrossRefGoogle Scholar
  14. Manning NJ, Olpin SE, Pollitt RJ et al (2000) Fumarate hydratase deficiency: increased fumaric acid in amniotic fluid of two affected pregnancies. J Inherit Metab Dis 23:757–759PubMedCrossRefGoogle Scholar
  15. Maradin M, Fumić K, Hansikova H et al (2006) Fumaric aciduria: mild phenotype in a 8-year-old girl with novel mutations. J Inherit Metab Dis 29:683PubMedCrossRefGoogle Scholar
  16. Morava E, Steuerwald U, Carrozzo R et al (2009) Dystonia and deafness due to SUCLA2 defect; Clinical course and biochemical markers in 16 children. Mitochondrion. doi: 10.1016/j.mito.2009.08.003 PubMedGoogle Scholar
  17. Ostergaard E, Hansen FJ, Sorensen N et al (2007a) Mitochondrial encephalomyopathy with elevated methylmalonic acid is caused by SUCLA2 mutations. Brain 130:853–861PubMedCrossRefGoogle Scholar
  18. Ostergaard E, Christensen E, Kristensen E et al (2007b) Deficiency of the alpha subunit of succinate-coenzyme A ligase causes fatal infantile lactic acidosis with mitochondrial DNA depletion. Am J Hum Genet 81:383–387PubMedCentralPubMedCrossRefGoogle Scholar
  19. Ostergaard E, Schwartz M, Batbayli M et al (2009) A novel missense mutation in SUCLG1 associated with mitochondrial DNA depletion, encephalomyopathic form, with methylmalonic aciduria. Eur J Pediatr. doi: 10.1007/s00431-009-1007-z PubMedGoogle Scholar
  20. Ottolenghi C, Hubert L, Allanore Y et al (2011) Clinical and biochemical heterogeneity associated with fumarase deficiency. Hum Mutat. doi: 10.1002/humu.21534 PubMedGoogle Scholar
  21. Picaud S, Kavanagh KL, Yue WW et al (2011) Structural basis of fumarate hydratase deficiency. J Inherit Metab Dis 34:671–676PubMedCentralPubMedCrossRefGoogle Scholar
  22. Rouzier C, Le Guédard-Méreuze S, Fragaki K et al (2010) The severity of phenotype linked to SUCLG1 mutations could be correlated with residual amount of SUCLG1 protein. J Med Genet 47(10):670–676. doi: 10.1136/jmg.2009.073445
  23. Surendran S, Michals-Matalon K, Krywawych S (2002) DOOR syndrome: deficiency of E1 component of the 2-oxoglutarate dehydrogenase complex. Am J Med Genet. 15;113(4):371–374Google Scholar
  24. Tomlinson IP, Alam NA, Rowan AJ (2000) Multiple Leiomyoma Consortium. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet 30:406–410Google Scholar
  25. Trinh BC, Melhem ER, Barker PB (2001) Multi-slice proton MR spectroscopy and diffusion weighted imaging in methylmalonic acidemia: report of two cases and review of the literature. Am J Neuroradiol 22:831–833PubMedGoogle Scholar
  26. Zeman J, Krijt J, Stratilová L et al (2000) Abnormalities in succinylpurines in fumarase deficiency: possible role in pathogenesis of CNS impairment. J Inherit Metab Dis 23:371–374PubMedCrossRefGoogle Scholar
  27. Zinn AB, Kerr DS, Hoppel CL (1986) Fumarase deficiency: a new cause of mitochondrial encephalomyopathy. N Engl J Med 315:469–475PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  1. 1.Department of PediatricsHayward Genetics Center, Tulane University Medical CenterNew OrleansUSA
  2. 2.Molecular GeneticBambino Gesù Children’s HospitalRomeItaly

Personalised recommendations